Overall, analgesics in Belgium, the largest OTC category, is projected to see stable retail current value sales over 2024 amid inflationary pressure. Beside the stability in retail value terms, retail volume sales of analgesics in Belgium is decreasing during 2024. The main reason for the decrease in retail volume sales in 2024 is that previous years, 2022 and 2023, saw a higher prevalence of influenza.
The Analgesics in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN BELGIUMDISCLAIMERDEFINITIONS
2024 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
